You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
Johnson and Johnson
Medtronic
Moodys

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Claims for Patent: 9,839,693

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,839,693
Title:Anhydrous hydrogel composition and delivery system
Abstract: The present disclosure relates to anhydrous hydrogels useful as mucoadhesive (oral compositions) or as topical agents and may be used to deliver an active agent such as active pharmaceutical agents (API\'s), coagulants, fragrances, flavors, and other actives and excipients.
Inventor(s): Borja; John (Keyport, NJ), Hayano; Stephanie Sharon (Millerton, NY)
Assignee: Acupac Packaging, Inc. (Mahwah, NJ)
Application Number:15/454,244
Patent Claims:1. A composition, comprising: a. sodium carboxymethyl cellulose (NaCMC) in an amount of from 5% (w/w) to 30% (w/w), said sodium carboxymethyl cellulose including minimal residual water; and b. anhydrous glycerine in an amount of from 70% (w/w) to 95% (w/w), wherein said composition is a solid or semi-solid gel composition.

2. The composition according to claim 1, further including an active agent in an amount of from 0.1% (w/w) to 30% (w/w).

3. The composition according to claim 2, wherein said active agent is cannabidiol (CBD).

4. The composition according to claim 2, wherein said active agent is selected from cannabidiol (CBD) oil and tetrahydrocannabinol (THC) oil.

5. The composition according to claim 1, wherein said anhydrous glycerin includes not more than 0.5% water.

6. The composition according to claim 2, wherein said active agent is moisture sensitive.

7. The composition according to claim 6, wherein said moisture sensitive active agent comprises pharmaceutical agents including biologicals, enzymes, proteins and fragments thereof, Adderall, alprazolam, gemifloxacin, hydromorphone and zolmitriptan.

8. The composition according to claim 2 wherein said active agent is a pharmaceutical agent selected from analgesics, decongestants, bronchodilators, antiasthmatic agents, cardiovascular agents, diabetic agents, antihistamines, anesthetics, antifungals, anti-nauseants, antiemetics, antibacterial agents, antifungal agents, corticosteroids, neurological agents, anti-inflammatories, vaccines, biological agents, wound healing agents, anticonvulsants and vitamins.

9. The composition according to claim 2 wherein said active agent is a wound healing agent selected from becaplermin, antimicrobial agents, silver, povidone-iodine, polyhexamethylene biguanide, dialkylcarbamoylchloride, lactoferrin, and growth factors.

10. The composition according to claim 2 wherein said active agent is a cosmetic agent.

11. The composition according to claim 10 wherein said active agent is the cosmetic agent ubiquinone.

12. The composition according to claim 2 wherein said active agent is a dental adhesive.

13. The composition according to claim 2 wherein said solid or semi-solid gel composition comprises: a. sodium carboxymethyl cellulose (NaCMC) in an amount of from 10% (w/w) to 20% (w/w); b. anhydrous glycerin in an amount of from 80% (w/w) to 90% (w/w); and c. active agent in an amount of from 0.1% (w/w) to 30% (w/w).

14. The composition according to claim 2 wherein said solid or semi-solid gel composition comprises: a. sodium carboxymethyl cellulose (NaCMC) in an amount of from 14% (w/w) to 16% (w/w); b. anhydrous glycerin in an amount of from 84% (w/w) to 86% (w/w); and c. the active agent in an amount of from 0.1% (w/w) to 30% (w/w).

15. The composition according to claim 2 wherein said solid or semi-solid gel composition is in unit dosage form.

16. A composition, comprising: a. sodium carboxymethyl cellulose (NaCMC) in an amount of from 5% (w/w) to 30% (w/w), said sodium carboxymethyl cellulose including minimal residual water; b. anhydrous glycerine in an amount of from 70% (w/w) to 95% (w/w); and c. cannabidiol (CBD) in an amount of from 0.1% (w/w) to 30% (w/w), wherein said composition is a solid or semi-solid gel composition.

17. A method of preparing a composition comprising: a. mixing to homogeneity the following: i. sodium carboxymethyl cellulose (NaCMC) in an amount of from 5% (w/w) to 30% (w/w), said sodium carboxymethyl cellulose including minimal residual water; and ii. anhydrous glycerine in an amount of from 70% (w/w) to 95% (w/w); and b. adding sufficient energy to transform the mixture into a solid or semi-solid gel composition.

18. The method according to claim 17, wherein said mixing step further includes adding an active agent in an amount of from 0.1% (w/w) to 30% (w/w).

19. The method according to claim 17 wherein the energy source is heat.

20. The method according to claim 17 wherein the energy source is radiation.

21. The method according to claim 20 wherein the energy source is heat.

22. The method according to claim 18, wherein the active agent is cannabidiol (CBD).

23. A kit comprising the composition of claim 1.

Details for Patent 9,839,693

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16   Start Trial Acupac Packaging, Inc. (Mahwah, NJ) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Boehringer Ingelheim
Johnson and Johnson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.